Overview

Study of SI000413 in Knee Osteoarthritis Patients

Status:
Unknown status

Trial end date:
2013-12-01

Target enrollment:

Participant gender:

Summary

The purpose of this study is to evaluate efficacy and safety of SI000413 in patients with knee osteoarthritis by orally administration and to determine optimal dose.

Phase:

Phase 2

Details

Lead Sponsor:

Dong-A Pharmaceutical Co., Ltd.